IVAX, Generic Giant Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX, Generic Giant

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark A. Stang who wrote (160)	4/6/1997 9:30:00 PM
From: James Silverman	of 212

Mark, If they can effectively restructure and in fact pursue a strategy to enhance shareholder value via selling units/spinning off units the $12 upside would probably be low. That said I also dont know the severity of their financial woes-noncompliance with debt covenants etc. The stock does appear oversold and I would guess that the bulk of the selling has been institutionally led. What IVX could use a healthy dose of is a kickass generic approval-among the recent approvals I'm not sure if any qualify as sole approvals or as blockbuster generics. As you well know the sector as a whole is struggling nearly across the board, pricing pressures have been fierce. IVX is not alone in the sector as an underperformer-PRX, CPLY, ALO, DRMD amongst others are are either losing money or are reporting negative growth and have been for the over a year. If IVX can clean their house and the pricing pressures ease, IVX should be in a solid position to turn around. So vague answer but buying IVX now would be a bet that their management can get the job done and get themselves into strong position when the sector inevitably turns around.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next